Position in GILD
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,783,776
+$984,040 QoQ
Shares Held
19,974
+36.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MCF Advisors LLC holds $24,166,889 across 16 Drug Manufacturers - General names. GILD ranks #6 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,429 | $5,971,424 | |
| 2 | AMGN |
Amgen Inc
|
11,665 | $4,104,330 | |
| 3 | LLY |
ELI LILLY & Co
|
3,526 | $3,243,109 | |
| 4 | MRK |
Merck & Co., Inc.
|
24,309 | $2,924,129 | |
| 5 | ABBV |
AbbVie Inc.
|
13,037 | $2,835,417 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
19,974 | $2,783,776 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,168 | $980,589 | |
| 8 | PFE |
Pfizer Inc
|
32,618 | $915,913 |
All Filings in GILD
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,783,776 | 19,974 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,799,736 | 14,663 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $995,448 | 8,968 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $700,698 | 6,320 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $704,906 | 6,291 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $626,176 | 6,779 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $391,365 | 4,668 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $326,171 | 4,754 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $538,241 | 7,348 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $582,947 | 7,196 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $496,327 | 6,623 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $477,756 | 6,199 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $534,907 | 6,447 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $536,304 | 6,247 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $282,725 | 4,583 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $228,758 | 3,701 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $246,895 | 4,153 | Shares | Sole | 2022-05-05 | |
| 2021-09-30 | $208,921 | 2,991 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $127,115 | 1,846 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $19,841 | 307 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||